On October 11, 2017, team members of the Institute for Advancing Translational Medicine (CCIR) in Bone & Joint Diseases (CCIR) attended the Yangcheng Lake Forum concerning aptamer-based drug R&D. Under the guidance of Prof. Ge Zhang, the academic staff in CCIR introduced their research topics and made a deep discussion with Prof. Yang Zhenjun for the key scientific concerns in the development of the aptamer-based drug.